Fig. 1From: Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II studyPatient disposition by individual treatment group. AE, adverse eventBack to article page